Literature DB >> 12644014

Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia.

Anna Zaninoni1, Francesca Guia Imperiali, Cristina Pasquini, Alberto Zanella, Wilma Barcellini.   

Abstract

OBJECTIVE: Dysregulation of the apoptotic mechanisms plays a key role in the accumulation of malignant B-chronic lymphocytic leukemia (B-CLL) cells. The transcription nuclear factor (NF)-kappaB is important for cell survival by regulating the expression of anti-apoptotic genes. Several cytokines can modulate leukemic growth and apoptosis in B-CLL. The aim of this study was to determine whether cytokine-mediated regulation of apoptosis occurs via modulation of NF-kappaB activity in peripheral blood mononuclear cells from B-CLL patients. PATIENTS AND METHODS: We evaluated NF-kappaB activity in peripheral blood mononuclear cells from 15 untreated B-CLL patients and 11 controls in resting conditions and in the presence of phorbol-12-myristate-13-acetate (PMA) and different cytokines by electrophoretic mobility shift assay. Apoptosis was studied by spectrophotometric analysis of DNA fragmentation.
RESULTS: We found a constitutive high NF-kappaB activity not induced by PMA in B-CLL patients, in contrast with a normal inducible NF-kappaB activity in controls. In B-CLL cultures, addition of interleukin (IL)-4 and IL-13 increased, whereas transforming growth factor (TGF)-beta reduced NF-kappaB activity compared with unstimulated cultures. Accordingly, IL-4 and IL-13 decreased, whereas TGF-beta increased DNA fragmentation compared with unstimulated cultures. IL-13 and IL-4 production was increased, whereas TGF-beta was reduced in PMA-stimulated and unstimulated cultures from B-CLL patients compared with controls.
CONCLUSIONS: B-CLL patients have a constitutive high NF-kappaB activity, which is modulated by cytokines. In particular, TGF-beta displays a pro-apoptotic activity, whereas IL-4 and IL-13 have opposite effects. These cytokine alterations could be responsible for a positive autocrine circuit that maintains leukemic cells in a pre-apoptotic state. Copyright 2003 International Society for Experimental Hematology

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644014     DOI: 10.1016/s0301-472x(02)01046-9

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

1.  Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.

Authors:  Kaneez Fatima; Rehan Zafar Paracha; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

Review 2.  New treatments for chronic lymphocytic leukemia.

Authors:  Asher A Chanan-Khan
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

3.  Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

Authors:  Asher A Chanan-Khan; Kasyapa Chitta; Noreen Ersing; Aneel Paulus; Aisha Masood; Taimur Sher; Abhisek Swaika; Paul K Wallace; Terry L Mashtare; Greg Wilding; Kelvin Lee; Myron S Czuczman; Ivan Borrello; Naveen Bangia
Journal:  Br J Haematol       Date:  2011-10-20       Impact factor: 6.998

4.  Expression and significance of nuclear factor kappaB p65 in colon tissues of rats with TNBS-induced colitis.

Authors:  Jun-Hua Li; Jie-Ping Yu; Hong-Gang Yu; Xi-Ming Xu; Liang-Liang Yu; Shi-Quan Liu
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

Review 5.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

6.  Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer.

Authors:  Zahra Faghih; Nasrollah Erfani; Mahboobeh Razmkhah; Safoura Sameni; Abdolrasoul Talei; Abbas Ghaderi
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

7.  Oxymatrine improves TNBS-induced colitis in rats by inhibiting the expression of NF-kappaB p65.

Authors:  Heng Fan; Rui Chen; Lin Shen; Jianfang Lv; Pengcheng Xiong; Zhexing Shou; Xiong Zhuang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-08-15

8.  NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion.

Authors:  Stefano Baldoni; Paolo Sportoletti; Beatrice Del Papa; Patrizia Aureli; Erica Dorillo; Emanuela Rosati; Raffaella Ciurnelli; Pierfrancesco Marconi; Franca Falzetti; Mauro Di Ianni
Journal:  Int J Hematol       Date:  2013-05-21       Impact factor: 2.490

9.  T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.

Authors:  Arun Kumar; Tingting Chen; Sari Pakkanen; Anu Kantele; Maria Söderlund-Venermo; Klaus Hedman; Rauli Franssila
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

10.  Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.

Authors:  Tiziana Vaisitti; Federica Gaudino; Samedy Ouk; Maria Moscvin; Nicoletta Vitale; Sara Serra; Francesca Arruga; Johannes L Zakrzewski; Hsiou-Chi Liou; John N Allan; Richard R Furman; Silvia Deaglio
Journal:  Haematologica       Date:  2017-08-31       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.